Inflammation: Cause or Consequence of Epilepsy? by Lee, Vanessa Lin Lin & Shaikh, Mohd. Farooq
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Inflammation: Cause or 
Consequence of Epilepsy?
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Abstract
Epilepsy is the third most common neurological disorder, affecting about 70 
million people worldwide. It is defined as a central nervous system disorder which 
affects the neuronal activity in the brain, causing unprovoked seizures and other 
behavioral changes. Unfortunately, one-third of epilepsy patients are unrespon-
sive to available therapies and patients who respond to antiepileptic drugs often 
complain of debilitating side effects. In the effort of devising a suitable therapy for 
epilepsy treatment, researchers delved into the origin of seizures and the epilepto-
genic process and found an association between epilepsy and inflammation. Here, 
we discuss the involvement of inflammatory mediators in the development and pro-
gression of seizures and epileptogenesis, supported by clinical shreds of evidence. 
Subsequently, we discuss the role of inflammation in the generation of seizures, as 
it is debatable whether inflammation is the cause or consequence of epilepsy, along 
with experimental models in inflammation and epilepsy research.
Keywords: inflammation, inflammatory mediators, seizures, epilepsy, animal 
models
1. Introduction
Epilepsy is a brain disorder denoted by the predisposition to generate seizures 
accompanied by emotional and cognitive dysfunction [1]. Currently, there are 
estimated to be 50–70 million people worldwide suffering from epilepsy but only 
about 70% of them respond well to existing antiepileptic drugs [2, 3]. Furthermore, 
epileptic patients suffer deteriorating quality of life as they face limitations on their 
physical activities and daily life as well as being subjected to prejudice due to their 
seizures [4]. This calls for more research to seek for novel and effective therapies for 
the management and treatment of epilepsy, by first understanding the basis for the 
onset and progression of seizures.
The exact cause of epilepsy is still unknown, but there are mounting evidence 
showing that the development of epileptogenesis can be linked to a wide array of 
factors such as genetic predisposition, developmental disorders and neurological 
insults [5]. Neurological insults, which contribute towards up to 60% of epilepsy 
cases, include traumatic brain injuries (TBI), cerebrovascular accidents (CVA), 
central nervous system (CNS) infections and strokes, where inflammation is one 
of the key features of epileptogenesis [6]. However, the role of inflammation in 
epilepsy is still being actively studied, with various arguments on whether inflam-
mation is the cause or consequence of epilepsy [7]. The blood-brain barrier (BBB), 
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which functions as a protector of the central nervous system, has an important role 
in regulating the transfer of blood constituents in the brain extracellular space [8]. 
Increased BBB permeability or BBB leakage is said to be one of the earliest charac-
teristics of the pathophysiology of epileptogenesis [9, 10]. BBB dysfunction may 
contribute to epileptogenesis via a cascade of events triggered by leakage of inflam-
matory mediators into the CNS which causes neuroinflammation [11, 12]. Here, 
we discuss briefly how neuroinflammation is involved in epileptogenesis as well as 
the status of inflammation in post-epileptic conditions; whether it is the cause or 
consequence of epilepsy, together with experimental evidences.
2. Inflammatory response in epilepsy
Considering inflammation as one of the culprits of epileptogenesis, neuroin-
flammation occurs as a result of a cascade of inflammatory pathways. This involves 
inflammatory and anti-inflammatory molecules as a response to noxious stimuli 
or immune stimulation; targeted to defend against pathogenic threats. The activa-
tion of inflammatory mediators such as interleukins (ILs), interferons (IFNs), 
cyclooxygenase (COX)-2 and nuclear factor kappa B (NF-κB), and the surplus of 
downstream inflammatory mediators including IL-1β, IL-6, tumor necrosis factor 
(TNF)-α and prostaglandin E2 (PGE2) contribute to seizure progression [13, 14]. 
Inflammatory mediators are produced by the glia, neurons, endothelial cells of the 
BBB and peripheral immune cells. In the presence of noxious stimuli, cytokines are 
secreted by immunocompetent and endothelial cells as well as glial and neuronal 
cells in the CNS. In the presence of noxious stimuli, cytokines are released which 
enable effective communication between effector and target cells [7, 15].
Both innate and adaptive immunity is known to contribute in the generation 
of inflammation in the brain via the microglia, astrocytes and neurons [7]. In a 
non-epileptic condition, innate immunity activation occurs during infection and 
is instrumental for pathogen recognition as well as removal via homeostatic-type 
tissue inflammation [16]. In epileptic condition where pathogens are absent, innate 
immunity signaling is activated by damage-associated molecular patterns (DAMPs) 
which are secreted by injured or activated neurons, bringing about a phenomenon 
called ‘sterile inflammation’ [17]. The microglia and astrocytes recognize proteins 
such as high mobility group box 1 (HMGB1), S100 proteins, adenosine triphosphate 
(ATP), migration inhibitory factor-related protein 8 (MRP8), which makes are 
DAMPs, extracellular matrix degradation products and IL-1β to induce inflamma-
tion [17, 18]. On top of that, the inflammatory signaling disrupts the BBB integrity 
by inducing up-regulation of adhesion molecules as well as leukocyte recruitment. 
These processes reduces seizure threshold and contribute to epileptogenesis and 
seizure recurrence in epilepsy models [19, 20].
Clinically, it is observed that patients with autoimmune diseases such as systemic 
lupus erythematosus (SLE), Hashimoto’s encephalopathy, Behcet’s disease, and 
Sjogren’s syndrome have an increased risk of developing epilepsy [5]. Another 
example of an autoimmune disease associated with a predisposition to seizures is 
Rasmussen encephalitis (RE), a rare inflammatory brain disease causing cerebral 
hemiatrophy, which progressively leads to severe seizures [21]. Patients of RE have 
higher levels of astrocytosis, proinflammatory mediators as well as lymphocytes 
and activated microglial cells in the brain [22, 23]. In these cases, usually, immuno-
therapies are more effective as compared to antiepileptic drugs in the management 
of epilepsy [24].
Moreover, a number of reports suggest that the onset and perpetuation of epi-
lepsy can be driven by inflammation and is not caused by the autoimmune process. 
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Upregulation of proinflammatory markers and inflammation-related microRNAs 
are found in patients of generalized seizures and temporal lobe epilepsy (TLE) 
[25, 26]. Butler, Li [27] reported a significantly greater inflammation intensity 
and spatial extent using positron emission tomography (PET) scan in post-seizure 
patients [27].
3. Experimental models
Moving forward with the understanding on the clinical association of inflamma-
tion with epileptogenesis, researchers sought to decipher the role of inflammation 
and associated pathways in the genesis of a seizure in the brain. Experimental mod-
els of inflammation have been instrumental in understanding the role of inflamma-
tion in epilepsy. It is still an ongoing debate as there are two field of thoughts; (1) 
inflammation acts as the cause of seizures and (2) inflammation is the consequence 
of seizures [7]. Here, we discuss the different types of experimental models and the 
outcomes of the experimental work, summarized in Table 1.
3.1 Inflammation increases seizure susceptibility
3.1.1 Hyperthermia-induced seizures
Febrile seizures (FS) are common in children aged between 6 months and 
5 years and occur in response to fever but without infection of the CNS. Fever is the 
elevation of the body temperature set point within the hypothalamus which results 
in an elevation of core temperature and is generated by inflammatory mediators 
such as cytokines and prostaglandins which then invokes a systemic inflamma-
tory response [28, 29]. A widely used hyperthermia-induced seizure model for 
studying FS is one in which hyperthermia is induced using a regulated stream of 
mildly heated air to increase the body temperature of neonatal rats aged 10–13 days 
[30–32]. The brain development of rats between 10 and 15 postnatal days best 
corresponds to the development of brain in human infants when they are most 
susceptible to FS [30]. The ‘ideal’ increase of core temperature in the pups is around 
2.9°C, which is reported to be parallel with the temperature increment observed in 
children experiencing FS [33].
In this model, seizures can be confirmed using electroencephalogram (EEG) 
[30]. The behaviors exhibited by the pups, such as biting tonic stiffening, and 
falling over, are similar to those observed after administration of convulsants. 
Generalized tonic seizures are rarely observed, however [30, 32]. In addition to 
biochemical analysis, behavioral tests such as the balance beam test and footprint 
test provide information on the severity and progression of seizures. Research has 
also shown that in this hyperthermic model, there is a remarkably high release of 
cytokines within the brain, specifically IL-1β within the hippocampus, and activa-
tion of astrocytes, which elevates the brain temperature. This finding is similar to 
those seen in children suffering from FS [31].
3.1.2 Systemic inflammation
Systemic inflammation is believed to have several CNS manifestations, such as 
fever, locomotor activity reduction and behaviors that are associated with brain 
hyperactivity during peripheral inflammation [34]. In other words, the inflam-
matory response which can be observed during the manifestation of peripheral 
inflammatory diseases is similar to the inflammatory response generated in the 
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periphery [35]. It is important to note that systemic inflammation alone is insuffi-
cient to induce seizures, and therefore, a double-hit with a proconvulsant is usually 
adopted in experiments to show that the first hit of existing inflammation predis-
poses the subject to increased seizure susceptibility in response to a second hit. We 
discuss two models of systemic inflammation which have been used for the study of 
epilepsy and seizures.
The first one is a model of inflammatory bowel disease [36–38]. Inflammatory 
colitis is induced in adult male rats by intracolonic administration of 2,4,6- 
trinitobenzene sulfonic acid (TNBS) to initiate a T helper-1 cell-mediated model 
of inflammatory bowel disease. A dose of 50 mg/mL, 50 mL per rat, invoked an 
Types of animal 
model
Dose/method Outcome References
Hyperthermic-
induced seizure
Using a regulated stream of 
mildly heated air to increase 
core temperature.
• Mimics febrile seizures in children.
• Core body temperature increase by around 
2.9°C.
• Marked release of cytokines within the 
brain and activation of astrocytes.
[28–31]
Inflammatory 
bowel disease 
model
Intracolonic administration of 
2,4,6-trinitobenzene sulfonic 
acid (TNBS) at a dose of 50 
mg/ml, 50mL per rat.
• Induces significant inflammatory response 
within the hippocampus.
• Activation of microglial.
• Increases levels of TNFα.
• Increases susceptibility to PTZ-induced 
seizures.
[32–35]
Escherichia coli 
LPS injection
Intraperitoneal injection of 5 
mg/kg or peritoneal infusion 
of 2.5 mg/kg/day for 7 days.
• Increases plasma levels of IL-1β, IL-6 and 
TNF-α.
• Increases body temperature slightly (by 
0.9°C).
• Increases seizure susceptibility.
[36–38]
Kainic acid 
injection
Intraperitoneal injection of 2 
mg/kg in rat neonates, 15 mg/
kg in adult rats and 20 mg/kg 
in mice, 6 mg/kg in zebrafish.
• Induces limbic seizures characterized by a 
seizure scale devised by Racine.
• Seizures induced resemble human temporal 
lobe epilepsy.
• Leads to neuronal cell death and induction 
of proinflammatory gene expression.
[39–44]
Pilocarpine 
injection
Subcutaneous or 
intraperitoneal injection of 
340–350 mg/kg in rats, 30 
mM in zebrafish larvae.
• Induces status epilepticus, followed by 
recurrent spontaneous seizures.
• Causes extensive neuronal cell loss, 
astrogliosis, and mossy fiber sprouting in 
hippocampus.
• Developmental exposure to pilocarpine 
shows very little effect to startle response.
[45–50]
Serum albumin 
injection
Intracerebroventricular 
injection of 1.9 mM in rats.
• Mimics BBB breakdown following seizures.
• Increased IL-1β immunoreactivity.
• Astrocyte dysfunction.
• Significant increase in interictal spikes and 
neuronal excitability.
• Reduction in seizure threshold.
[51]
Table 1. 
Animal models in epilepsy studies.
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acute form of localized inflammatory colitis. To study the susceptibility to seizures, 
a convulsant, pentylenetetrazole (PTZ) was given through intravenous infusion to 
induce seizures. In this study by Riazi et al. [38], they found that TNBS-treated rats 
express increased susceptibility to PTZ-induced seizures that strongly correlates 
with the severity and progression of intestinal inflammation. The TNBS-treated rats 
present a prominent and reversible inflammatory response within the hippocampus 
along with microglial activation and TNF-α level elevation [38]. The inflammatory 
colitis model is also used by Rao, Medhi [39] to establish the correlation between 
systemic inflammation and seizures. They induced colitis using a method described 
by MacPherson and Pfeiffer [40], which is the application of acetic acid on the 
colonic lumen of adult rats. They too found that systemic inflammation can be 
associated with a decreased threshold to PTZ-induced seizures [39].
The second model of systemic inflammation is bacterial lipopolysaccharide 
(LPS) injection. In adult rats, an intraperitoneal injection of LPS results in an 
increase in body temperature elicited by an inflammatory response, which mimics 
febrile seizures, though a second-hit with a pro-convulsant drug, usually kainic 
acid, is usually required to generate febrile convulsions. LPS increases rat’s body 
temperature by 1–1.5°C, which mimics fever and amplifies the convulsant actions 
of KA [41]. Single intraperitoneal injection of Escherichia coli LPS at 5 mg/kg or 
infusion of at a dose of 2.5 mg/kg/day into the peritoneal cavity of adult rats for 
7 days via an osmotic mini-pump is sufficient to induce peripheral inflammation 
[42, 43]. In mice, a single dose of 1 mg/kg of LPS i.p. is sufficient to elicit effects 
on body temperature and seizure susceptibility [44]. Seizure susceptibility is then 
tested using an intraperitoneal injection of KA (10 mg/kg) or PTZ (10 mg/mL) 
after 2 hours [43, 44]. LPS infusion is reported to increase plasma levels of IL-1β, 
IL-6 and TNF-α. This means that the systemic inflammation induced by LPS infu-
sion brings about the activation of microglia, enhancement of pro-inflammatory 
cytokines production and tissue oxidative stress in the hippocampus [43, 45]. 
As a result, LPS administration increases body temperature slightly and reduces 
PTZ-induced seizure susceptibility in a dose-dependent and time-dependent 
manner. Recent studies have shown that LPS acts as an activator for Toll-like 
receptor 4 (TLR 4) and induces seizures. The probable mechanism in explanation 
to this is that LPS mimics the actions stressed or damaged neurons which releases 
endogenous ‘danger signals’ via a protein called HMGB1. After being released from 
neurons, HMGB1 communicates with TLR4 to induce seizures, which activates 
a positive feedback cycle, by stimulating activated astrocytes and microglia for 
additional release of HMGB1.
3.2 Inflammation as a consequence of seizures
3.2.1 Kainic acid (KA) injection
KA is an agonist for α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid 
(AMPA) and KA receptor. AMPA is a subtype of ionotropic glutamate receptor. 
Systemic and intracerebral injections of KA induce progressive limbic seizures, 
which resemble human temporal lobe epilepsy, in rats [46]. These peak in status 
epilepticus (SE) where, in limbic structures (i.e. hippocampal CA1 and CA3, and 
the hilus of dentate gyrus) of the brain, reactive oxygen species (ROS) production 
and mitochondrial dysfunction lead to neuronal cell death [47]. Moreover, the 
delayed release of proinflammatory gene expressions, such as TNF-α, IL-1β, IL-6, 
inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), is believed 
to promote prolonged neurodegeneration [48]. For these reasons, KA is used for 
various studies into neurological disorders including inflammation and epilepsy.
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Kainic acid injection into hippocampus of rats increases the number of IL-1ß, 
IL-6 and TNF-α positive cells in the hippocampus, indicating inflammatory 
response [49, 50]. There is also a higher number of GFAP-positive cells which shows 
that kainic acid promotes gliosis, also an indicator of neuroinflammation. Chen, 
Zhu [49] found that kainic acid administration causes swelling and deformities of 
endothelial cells and their nuclei in cerebromicrovessels. The BBB integrity is also 
destroyed following kainic acid injection with signs of vacuolation, perivascular 
edema and membrane damage [49].
KA is widely used in epilepsy studies and models include rodents as well as 
zebrafish. In rodents, KA works to induce seizures and SE in neonatal and adult 
rat and mice. In rat neonates, 2 mg/kg of KA injected intraperitoneally was found 
to induce seizures without mortality while 4 mg/kg of KA was shown to induce 
mortality in 60% of pups [51]. For adult rats and mice, a single dose of KA at15mg/
kg for rats and 20 mg/kg for mice can be used for inducing seizures [52].
In rat neonates, the phases of convulsions that are generated by KA are automa-
tism (forelimb/hind-limb scratching) and continuous generalized tonic-clonic 
seizures, with loss of righting reflex, indicating tonic extension and SE. In this 
model, SE is defined as continuous clonic seizures involving both forelimbs and 
hind-limbs and continual loss of the righting reflex [51].
In adult rats and mice, seizures are characterized by a seizure scoring scale 
devised by Racine as follows:
Stage 1: Wet dog shakes, facial clonus and staring.
Stage 2: Head nodding.
Stage 3: Forelimb clonus.
Stage 4: Forelimb clonus with rearing.
Stage 5: Rearing, jumping, falling and SE.
Despite being a relatively new model, zebrafish is acknowledged to be a fairly 
popular animal model in pre-clinical researches and as a suitable alternative to 
rodents and other animal models in epilepsy research [53]. KA is used to induce 
seizures in zebrafish at a dose of 6 mg/kg, injected intraperitoneally. The seizures 
induced by KA are characterized as follows [54]:
Stage 1: Immobility and hyperventilation.
Stage 2: Whirlpool-like swimming behavior.
Stage 3: Rapid left-to-right movements.
Stage 4: Abnormal and spasmodic muscular contractions.
Stage 5: Rapid, whole-body, clonus-like convulsions.
Stage 6: Death.
SE is represented by seizure scores fluctuating between 4 and 6 for a period of 
30 minutes or more [55].
3.2.2 Pilocarpine injection
Pilocarpine is a cholinergic (muscarinic) agonist which induces SE, followed by 
recurrent spontaneous seizures (RSS), in animal models and is widely used to study the 
mechanisms of SE. It acts on the endothelial muscarinic receptors which compromises 
the integrity of the BBB [56]. It subsequently causes the influx of proinflammatory 
cytokines into the brain, which results in neuroinflammation [35]. The hippocampus 
is notably more vulnerable to pilocarpine-induced neuronal injury because it possesses 
numerous distinct neuronal circuits which are involved in the generation of seizures 
[57]. Pilocarpine causes extensive neuronal cell loss in CA1 and CA3 pyramidal cell 
layers, astrogliosis, and mossy fiber sprouting in the hippocampus [57, 58].
Upon administration of pilocarpine into rats, the levels of inflammatory 
biomarkers, IL-1β, TNF-α, NF-κβ and COX-2, are elevated in the hippocampus, 
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indicating the presence of neuroinflammation [59]. During pilocarpine-induced 
seizures, ROS formation increases and glutathione (GSH) redox status becomes 
impaired in the hippocampus [60, 61]. The overproduction of ROS leads to an 
increase in oxidative stress which contributes to cell apoptosis in the brain [62]. Ali, 
Mahdy [59] reported that pilocarpine injection induces a significant elevation of 
hippocampal cytochrome c and caspase 3 levels which contributes to apoptosis. This 
apoptotic cell death is a key feature of hippocampal cell loss induced by SE [59]. 
Furthermore, apoptosis related proteins such as Bax, Bcl-2 family and caspase-3 can 
modify the neurotransmission pathways that are independent of cell death in the 
CNS and have significant contribution in epileptogenesis [63, 64].
Seizures can be induced in adult mice or rats with a subcutaneous or intraperito-
neal injection of 340–350 mg/kg of pilocarpine hydrochloride [58, 65]. Pilocarpine 
treatment sequentially induces the following behavioral changes: akinesia, facial 
automatisms, forelimb clonus with rearing, salivation, masticatory jaw movements 
and falling [65, 66]. These behaviors build up progressively into motor limbic 
seizures that recur repeatedly and rapidly develop into SE, similar to that described 
in patients of temporal lobe epilepsy (TLE). EEG findings showed a significant 
surge of theta rhythms and isolated spikes in the hippocampus, synchronization 
of the hippocampal and cortical activities, isolated electrographic seizures and SE 
[65]. The electroencephalographical, behavioral, as well as anatomical alterations 
and characteristics of human TLE are emulated by this model [58].
Besides the rodent models, pilocarpine is also used to induce seizures in zebraf-
ish larvae for anticonvulsant studies. A final concentration of 30 mM of pilocarpine 
is used with a 1-minute incubation before quantification of larval locomotor activ-
ity. Exposure to pilocarpine results in a more subtle convulsive behavior compared 
to PTZ, such as lurching/head banging, head-to-tail undulations, increased mouth 
movements, tremor, body contortions and loss of posture [67]. Eddins, Cerutti [68] 
reported the use of pilocarpine to induce seizures in zebrafish embryos to compare 
its effects on early exposure to developmental exposure to toxicants. Zebrafish 
embryos (2-hours post-fertilization) exposed to 100 μM pilocarpine exhibit very 
little to zero dose–response relationship of developmental pilocarpine exposure 
with regard to the startle response [68].
3.2.3 Albumin injection
Extravasation of serum albumin into the brain provokes prominent BBB 
dysfunction through the activation of transforming growth factor beta (TGF-β) 
receptor (RII) signaling. This causes the astrocytes to fail in buffering extracellular 
K+ which causes BBB dysfunction [69–71]. BBB dysfunction is a commonly found 
following seizures or epileptogenic brain injuries [7].
Frigerio et al. [72] described a model using albumin to provoke BBB breakdown, 
mimicking brain excitability after SE. They showed that a single intracerebroven-
tricular injection of albumin to rats causes the diffusion of albumin into the hip-
pocampus before conveyed into principal neurons. The extravasation of albumin by 
parenchymal cells at pathological concentration causes the following conditions: (1) 
down-regulation of Kir4.1 channels and neuroinflammation in glial fibrillary acidic 
protein(GFAP)-positive astrocytes; (2) brief neuronal hyperexcitability manifested 
as involuntary epileptic spikes, and amplified KA–induced epileptic activity; and 
(3) chronic reduction in seizure threshold without causing cell loss or spontaneous 
epileptic activity [72].
BBB disruption was induced using a single dose of intracerebroventricular injec-
tion of 1.9 mM rat albumin into deeply anesthetized adult rats. After the injection, 
GFAP-positive glial cells and IL-1β staining in the hippocampus were evaluated. It 
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was found that albumin injection prominently increases IL-1β immunoreactivity in 
GFAP-positive astrocytes and the number of IL-1β immunopositive cells, indicating 
the presence of inflammation. Besides that, the production of rapid onset and tran-
sient spiking activity in the hippocampus can be found on the EEG analysis of rats 
injected with rat albumin. This means that the injection of albumin provokes the 
increase in neuronal excitability. Interestingly, rats presented a significant decline in 
seizure threshold 3 months after albumin injection. This suggests that acute tissue 
exposure to albumin induces a long-lasting increase in brain excitability [72].
In short, this model is able to show the pro-ictogenic effect of serum albumin in 
the brain, mimicking those attained after prolonged seizures and BBB dysfunction. 
Albumin induces the production of inflammatory molecules and together, they 
significantly increase brain excitability and seizure susceptibility although insuf-
ficient to trigger spontaneous seizures.
4. Conclusion
Inflammation plays an important role in the development of epilepsy and under-
standing this inflammatory process that happens during epileptogenesis could 
provide a strong basis for drug development and therapeutic approaches. We briefly 
highlighted the inflammatory response during epilepsy and some clinical correla-
tion. Besides, we outlined the experimental findings in epilepsy research pertaining 
to inflammation and hope to clear the doubts as to whether inflammation is a cause 
or consequence of epilepsy. Evidently, inflammation can be both the cause as well as 
consequence of epilepsy. Inflammation due to hyperthermia or infection activates 
the release of inflammatory molecules which increases seizures susceptibility. On 
the other hand, BBB dysfunction and prolonged seizures cause an influx of inflam-
matory molecules which causes neuroinflammation to take place.
Anti-inflammatory drugs, such as acetaminophen, celecoxib or aspirin, along 
with other anti-inflammatory agents such as anti-MGB1 antibodies and COX-2 
inhibitors have been shown to possess anti-convulsant properties [73]. Therefore, 
we suggest incorporating anti-inflammatory drugs into anti-epileptic treatments 
or therapy could be beneficial in the management of epilepsy and ameliorating co-
morbidities and side effects that could be exacerbated by neuroinflammation.
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